contact ENG | FR

beneath
the surface

It’s our viewpoint that new biological discoveries combined with a new era of advanced technologies are revolutionizing the field of small molecule drug discovery. In this series of videos, luminary scientists in the fields of immunology, structural biology, and computational chemistry join members of the Ventus team to share their insights into new ways to design medicines to reach elusive drug targets.

Tackling Neuroinflammation to Treat Major Brain Diseases with Anick Auger, MSc, Head of Pharmacology, Ventus Therapeutics and Marcelo Bigal, MD, PhD, President and CEO, Ventus Therapeutics

The future is every day that we get closer to make an undruggable, profoundly biologically important target druggable.
- Marcelo Bigal, MD, PhD
I've always wanted to be directly involved in putting a drug on the market. since I've joined Ventus, I'm starting to think that this is going to happen.
- Anick Auger, MSc

Small Molecules Are About to Be Big Again with Jason Burch, PhD, Head of Chemistry, Ventus Therapeutics

Water Dynamics and a New Era for Computational Chemistry with Thomas Kurtzman, PhD, Professor, Department of Chemistry, Lehman College, City University of New York and Dan McKay, BSc, MSc, Head of Computational Chemistry, Ventus Therapeutics

Unlocking Nucleic Acid Sensing Pathway Drug Targets with Kelly Pike, PhD, Head of Immunology and Scientific Affairs, Ventus Therapeutics and Thomas Tuschl, PhD, Professor of RNA Molecular Biology, The Rockefeller University

Prime Time for the Inflammasome with Richard A. Flavell, PhD, D.Sc, FRS, HHMI Investigator, Sterling Professor of Immunobiology, Yale School of Medicine and Michael Crackower, PhD, Chief Scientific Officer, Ventus Therapeutics

Shining a Light on NLRP3 with Michael Crackower, PhD, Chief Scientific Officer, Ventus Therapeutics and Hao Wu, PhD, Professor of Structural Biology, Harvard Medical School and Boston Children’s Hospital

Innate Immunity and Elusive Targets with Marcelo Bigal, MD, PhD, President and CEO of Ventus Therapeutics and Judith Lieberman, MD, PhD, Professor of Pediatrics, Harvard Medical School